INFLUENCE OF NEUTROPHIL/LYMPHOCYTE RATIO ON PROGNOSIS IN MUSHROOM POISONING

被引:0
|
作者
Koylu, Ramazan [1 ]
Dundar, Zerrin Defne [2 ]
Koylu, Oznur [3 ]
Gunaydin, Yahya Kemal [1 ]
Akilli, Nazire Belgin [1 ]
Mutlu, Huseyin [1 ]
Gonen, Mustafa Onder [1 ]
Yortanli, Mehmet [1 ]
Cander, Basar [2 ]
机构
[1] Konya Training & Res Hosp, Emergency Dept, Konya, Turkey
[2] Necmettin Erbakan Univ, Meram Fac Med, Dept Emergency Med, Konya, Turkey
[3] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
来源
ACTA MEDICA MEDITERRANEA | 2014年 / 30卷 / 04期
关键词
mushroom poisoning; neutrophill lymphocyte ratio; OXIDATIVE STRESS; LYMPHOCYTE RATIO; RENAL-FAILURE; NEUTROPHIL; ASSOCIATION; INGESTION; OUTCOMES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Mushroom poisoning is a severe poisoning which is commonly seen, particularly, in spring and autumn and may be fatal. This study aimed to study the influence of the neutrophil/lymphocyte ratio on prognosis in patients hospitalized in the toxicology unit with a diagnosis of mushroom poisoning. Methods: A total of 236 patients, admitted to the emergency room and hospitalized due to mushroom poisoning between July 2008 and March 2013, were retropsectively analysed. Patients were analysed in terms of age, gender, medical history, type of mushroom ingested, onset time of symptoms, complaints upon admission, and whether they received extracorporeal therapy and laboratory tests. Results: The mean age of patients hospitalized with mushrom poisoning was 41.88 +/- 17.81 years. Of the patients, 95 (40.3%) were male and 141 (59.7%) were female. In their medical history, 15 (64%) patients had diabetes mellitus, 8 (3.4%) had hypertension and 7 (3.0%) had coronary artery disease. 100 (42.4%) patients had eaten cultivated mushrooms, and 104 (44.1%) had eaten wild mushrooms. The mushroom type could not be determined in 32 (3.6%) patients. Symptoms appeared within the first 6 hours in 99 (843%) patients and after 6 hours in 37 (15.7%). Patients were usually admitted with nausea, vomiting, abdominal pain and diarrhea. 24 (10.2%) patients required hemoperfusion during their follow-up and treatment. Duration of hospital stay was 2.28 +/- 2.20 days in patients with normal liver functions, and 2 (0.8%) patients died. Neutrophil/lymphocyte ratio was 15.14 +/- 15.76 in patients with impaired liver functions, and this was statistically significant compared to patients with normal liver function tests (5.48 +/- 7.69) (p=0.001). Conclusions: These results indicated that patients whose neutrophil/lymphocyte ratio is high upon admission should be monitored carefully both for prognosis and hemoperfusion requirement considering longer duration of hospital stay and more aggressive treatment options.
引用
收藏
页码:849 / 854
页数:6
相关论文
共 50 条
  • [21] The Prognosis of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Elderly with Acute Ischemic Stroke
    Wang, Jing
    Zhao, Yan
    Lv, Cunming
    Li, Feng
    CLINICAL INTERVENTIONS IN AGING, 2024, 17 : 1715 - 1720
  • [22] Assessment of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Prognosis of Oral Squamous Cell Carcinoma
    Tazeen, Sanah
    Prasad, Kavitha
    Harish, Krishnamachar
    Sagar, Parimala
    Kapali, Aravind S.
    Chandramouli, Satish
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2020, 78 (06) : 949 - 960
  • [23] Associations between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and prognosis in patients with neuroblastoma
    Mirzayeva, Gunay
    Kupeli, Serhan
    Ozkan, Ayse
    Sezgin, Gulay
    Bayram, Ibrahim
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [24] Neutrophil-to-lymphocyte ratio versus platelet-to-lymphocyte ratio in predicting clinical outcomes in acute methanol poisoning
    Abdelwahab, Hanan M.
    Nafea, Ola E.
    Elsherif, Radwa
    Gharib, Amal F.
    Alrehaili, Amani A.
    Abdelhamid, Walaa G.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [25] Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis
    Kim, Ju-Yeon
    Jung, Eun Jung
    Kim, Jae-Myung
    Lee, Han Shin
    Kwag, Seung-Jin
    Park, Ji-Ho
    Park, Taejin
    Jeong, Sang-Ho
    Jeong, Chi-Young
    Ju, Young-Tae
    BMC CANCER, 2020, 20 (01)
  • [26] Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma
    Ke Li
    Wen-chao Duan
    Hai-biao Zhao
    Li Wang
    Wei-wei Wang
    Yun-bo Zhan
    Tao Sun
    Feng-jiang Zhang
    Bin Yu
    Ya-hui Bai
    Yan-min Wang
    Yu-chen Ji
    Jin-qiao Zhou
    Xian-zhi Liu
    Zhi-feng Zhang
    Zhen-yu Zhang
    Scientific Reports, 9
  • [27] Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma
    Li, Ke
    Duan, Wen-chao
    Zhao, Hai-biao
    Wang, Li
    Wang, Wei-wei
    Zhan, Yun-bo
    Sun, Tao
    Zhang, Feng-jiang
    Yu, Bin
    Bai, Ya-hui
    Wang, Yan-min
    Ji, Yu-chen
    Zhou, Jin-qiao
    Liu, Xian-zhi
    Zhang, Zhi-feng
    Zhang, Zhen-yu
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke
    Chen, Cuiping
    Gu, Lei
    Chen, Luyun
    Hu, Wangwang
    Feng, Xiaowen
    Qiu, Fengzhen
    Fan, Zijian
    Chen, Qitao
    Qiu, Jiayou
    Shao, Bei
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [29] Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis
    Ju-Yeon Kim
    Eun Jung Jung
    Jae-Myung Kim
    Han Shin Lee
    Seung-Jin Kwag
    Ji-Ho Park
    Taejin Park
    Sang-Ho Jeong
    Chi-Young Jeong
    Young-Tae Ju
    BMC Cancer, 20
  • [30] Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer
    Huszno, Joanna
    Kolosza, Zofia
    Mrochem-Kwarciak, Jolanta
    Telka, Ewa
    Jochymek, Bozena
    Miszczyk, Leszek
    ONCOLOGY LETTERS, 2022, 24 (03)